E Jacky

1.8k total citations
25 papers, 1.3k citations indexed

About

E Jacky is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E Jacky has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E Jacky's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). E Jacky is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). E Jacky collaborates with scholars based in Switzerland, Netherlands and Belgium. E Jacky's co-authors include Leo F. Verdonck, Bob Löwenberg, Peter C. Huijgens, Wim L.J. van Putten, Edo Vellenga, Martin F. Fey, Marc Boogaerts, Georgine E. de Greef, Gert J. Ossenkoppele and Dimitri Breems and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

E Jacky

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Jacky Switzerland 15 882 370 314 287 173 25 1.3k
G. L. Phillips Canada 20 931 1.1× 366 1.0× 507 1.6× 265 0.9× 325 1.9× 47 1.6k
Anne Marie Stoppa France 18 844 1.0× 242 0.7× 322 1.0× 555 1.9× 196 1.1× 43 1.2k
Emma Das‐Gupta United Kingdom 18 725 0.8× 290 0.8× 261 0.8× 425 1.5× 180 1.0× 34 1.2k
Bitran Jd United States 14 596 0.7× 247 0.7× 431 1.4× 272 0.9× 135 0.8× 33 1.2k
M. L. Vegna Italy 14 765 0.9× 183 0.5× 296 0.9× 517 1.8× 218 1.3× 20 1.2k
Mitchell Sabloff Canada 21 955 1.1× 336 0.9× 307 1.0× 294 1.0× 279 1.6× 68 1.5k
Elena Oldani Italy 18 570 0.6× 331 0.9× 441 1.4× 173 0.6× 236 1.4× 41 1.2k
Susan McKenzie United States 14 766 0.9× 439 1.2× 342 1.1× 367 1.3× 247 1.4× 19 1.2k
Esteban Abella United States 17 551 0.6× 202 0.5× 512 1.6× 178 0.6× 155 0.9× 56 1.3k
Eros Di Bona Italy 17 835 0.9× 431 1.2× 169 0.5× 394 1.4× 184 1.1× 46 1.1k

Countries citing papers authored by E Jacky

Since Specialization
Citations

This map shows the geographic impact of E Jacky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Jacky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Jacky more than expected).

Fields of papers citing papers by E Jacky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Jacky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Jacky. The network helps show where E Jacky may publish in the future.

Co-authorship network of co-authors of E Jacky

This figure shows the co-authorship network connecting the top 25 collaborators of E Jacky. A scholar is included among the top collaborators of E Jacky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Jacky. E Jacky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pabst, Thomas, Edo Vellenga, Wim van Putten, et al.. (2012). Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine. Blood. 119(23). 5367–5373. 65 indexed citations
2.
Köhler, Stefanie, Oliver Tschopp, E Jacky, & Christoph Schmid. (2011). Paraneoplastic hyperthyroidism: Figure 1. BMJ Case Reports. 2011. bcr0420114163–bcr0420114163. 6 indexed citations
5.
Andreisek, Gustav, et al.. (2004). Rektale Manifestation eines B-Zell-Non-Hodgkin-Lymphoms: Eine seltene Ursache von anorektalen Schmerzen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(9). 1329–1331. 1 indexed citations
6.
Greef, Georgine E. de, Wim L.J. van Putten, Marc Boogaerts, et al.. (2004). Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON‐SAKK co‐operative group studies. British Journal of Haematology. 128(2). 184–191. 44 indexed citations
7.
Jermann, Monika, L.M. Jost, E Jacky, et al.. (2004). Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Annals of Oncology. 15(3). 511–516. 64 indexed citations
8.
Trojan, Andreas, Helen I. Joller‐Jemelka, Rolf A. Stahel, E Jacky, & Martin Hersberger. (2004). False-Positive Human Serum Chorionic Gonadotropin in a Patient with a History of Germ Cell Cancer. Oncology. 66(4). 336–338. 9 indexed citations
9.
Jacky, E, et al.. (2003). Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia. Annals of Hematology. 82(3). 193–196. 5 indexed citations
10.
Morant, R., S.‐F. Hsu Schmitz, J. Bernhard, et al.. (2002). Vinorelbine in androgen-independent metastatic prostatic carcinoma—a phase II study. European Journal of Cancer. 38(12). 1626–1632. 25 indexed citations
13.
Sauter, C. & E Jacky. (1998). Chloroma in Acute Myelogenous Leukemia. New England Journal of Medicine. 338(14). 969–969. 5 indexed citations
14.
Berardi, Simona, et al.. (1998). Increased urinary excretion of carnitine in patients treated with cisplatin. European Journal of Clinical Pharmacology. 54(7). 503–508. 56 indexed citations
15.
Fopp, M., Martin F. Fey, M. Bacchi, et al.. (1997). Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine. Annals of Oncology. 8(3). 251–257. 28 indexed citations
16.
Christ, Emanuel, et al.. (1996). Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid.. PubMed. 10(4). 731–4. 55 indexed citations
17.
Jost, L.M., E Jacky, Corina Dommann‐Scherrer, et al.. (1995). Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt’s lymphomas in adult patients. Annals of Oncology. 6(5). 445–451. 29 indexed citations
18.
Stahel, Rolf A., L.M. Jost, Thomas Cerny, et al.. (1994). Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.. Journal of Clinical Oncology. 12(9). 1931–1938. 73 indexed citations
19.
Wernli, Martin, André Tichelli, V von Fliedner, et al.. (1994). Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. British Journal of Haematology. 87(1). 39–43. 14 indexed citations
20.
Pichert, Gabriella, et al.. (1993). [5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].. PubMed. 123(18). 932–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026